RT Journal Article
SR Electronic
T1 Neurobehavioral Differences in Superselective Wada Testing with Amobarbital versus Lidocaine
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 1456
OP 1460
VO 24
IS 7
A1 Fitzsimmons, Brian-Fred M.
A1 Marshall, Randolph S.
A1 Pile-Spellman, John
A1 Lazar, Ronald M.
YR 2003
UL http://www.ajnr.org/content/24/7/1456.abstract
AB Summary: Four patients with cerebral arteriovenous malformations (AVMs) underwent superselective Wada testing with intraarterial amobarbital and lidocaine before embolization. In all four patients, the use of lidocaine detected clinically significant neurologic deficits that amobarbital alone did not, likely because of the pharmacodynamic differences of the two agents. The use of lidocaine with amobarbital for superselective Wada testing in patients with cerebral AVMs may improve the sensitivity and predictive value of this test in the future.